Higher Intake of Red Meat Linked to Increased Risk for Dementia
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 15, 2025 -- Higher intake of red meat, especially processed red meat, is associated with an increased risk for developing dementia and subjective cognitive decline (SCD), according to a study published online Jan. 15 in Neurology.
Yuhan Li, from the Harvard T.H. Chan School of Public Health in Boston, and colleagues conducted a prospective cohort study to examine the association between red meat intake and cognitive outcomes. Participants free of dementia at baseline from two nationwide cohort studies were included; a validated semiquantitative food frequency questionnaire was used to assess diets.
The researchers found that the risk for dementia and SCD was increased for participants with processed red meat intake ≥0.25 versus <0.1 serving per day (hazard ratio of 1.13 and relative risk of 1.14, respectively). Accelerated aging in global cognition and in verbal memory was seen in association with higher processed red meat intake (1.61 and 1.69 years per one serving per day increment, respectively). A higher risk for SCD was seen in association with unprocessed red meat intake of ≥1.00 versus <0.5 serving per day (relative risk, 1.16). Replacing processed red meat with one serving per day of nuts and legumes was associated with a lower risk for dementia (hazard ratio, 0.81), 1.37 fewer years of cognitive aging, and a lower risk for SCD (relative risk, 0.79).
"Replacing processed red meat with healthier protein sources such as fish, poultry, eggs, low-fat dairy, nuts, and legumes may have substantial benefits for maintaining cognitive health," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1...
Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI
FRIDAY, July 11, 2025 -- For adults with chronic low back pain, gabapentin prescription is associated with an increased risk for dementia and mild cognitive impairment (MCI)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.